Fulcrum Therapeutics Inc (NASDAQ: FULC) kicked off on Monday, up 45.96% from the previous trading day, before settling in for the closing price of $8.9. Over the past 52 weeks, FULC has traded in a range of $2.32-$12.19.
Healthcare Sector giant saw their annual sales surged by 54.59% over the last five years. While this was happening, its average annual earnings per share was recorded -633.75%. With a float of $48.00 million, this company’s outstanding shares have now reached $54.11 million.
Fulcrum Therapeutics Inc (FULC) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Fulcrum Therapeutics Inc is 11.30%, while institutional ownership is 89.92%. The most recent insider transaction that took place on Dec 08 ’25, was worth 54,235,056. Before that another transaction happened on Nov 19 ’25, when Company’s Director sold 15,000 for $11.03, making the entire transaction worth $165,495. This insider now owns 484,864 shares in total.
Fulcrum Therapeutics Inc (FULC) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.31 earnings per share (EPS), lower than consensus estimate (set at -0.29) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -633.75% per share during the next fiscal year.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Trading Performance Indicators
Take a look at Fulcrum Therapeutics Inc’s (FULC) current performance indicators. Last quarter, stock had a quick ratio of 17.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.21 in one year’s time.
Technical Analysis of Fulcrum Therapeutics Inc (FULC)
Analysing the last 5-days average volume posted by the [Fulcrum Therapeutics Inc, FULC], we can find that recorded value of 5.75 million was better than the volume posted last year of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 23.86%.
During the past 100 days, Fulcrum Therapeutics Inc’s (FULC) raw stochastic average was set at 70.95%, which indicates a significant increase from 61.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.06 in the past 14 days, which was higher than the 0.63 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.40, while its 200-day Moving Average is $6.65. Now, the first resistance to watch is $14.91. This is followed by the second major resistance level at $16.82. The third major resistance level sits at $17.91. If the price goes on to break the first support level at $11.91, it is likely to go to the next support level at $10.82. Now, if the price goes above the second support level, the third support stands at $8.91.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Key Stats
The company with the Market Capitalisation of 702.99 million has total of 54,118K Shares Outstanding. Its annual sales at the moment are 80,000 K in contrast with the sum of -9,730 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -19,600 K.
